Skip to content

Efficacy of contrast enhanced spectral mammography (CESM)

Efficacy of contrast enhanced spectral mammography (CESM) - Efficacy of contrast enhanced spectral mammography (CESM)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005680
Enrollment
60
Registered
2011-05-31
Start date
2011-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Category 3 or more in mammography or ultrasound

Interventions

Sponsors

Showa University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Category 3 or more in mammography or ultrasound within one year 2)Female aged over 20 3) Written informed consent

Exclusion criteria

Exclusion criteria: 1) respiratory disorder; asthma, chronic obstractive respiratory disease, lung cancer 2) history of allergic reaction to iodinate contrast medium, drug or food 3) history of thyroid disease 4) diabetes mellitus taking metformin 5) brain disease, heart disease, liver disease or kidney disease 6) acute pancreatitis, microglobulinemia, multiple myeloma, tetany or phenochromocytoma 7) History of breast enlargement injection or surgery 8) pregnancy or during lactation 9) mental disorder 10) participating or have participated within 3 months in other trials 11) other disorders which may prevent accurate evaluation.

Design outcomes

Primary

MeasureTime frame
accuracy rate

Secondary

MeasureTime frame
true positive rate, false negative rate, true negative rate, false positive rate, adverse events

Countries

Japan

Contacts

Public ContactMiki Mori

Showa University Department of breast surgical oncology

03-3784-8511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026